@article{article, title  = {{A randomized, double-blind, biomarker-selected, phase II clinical trial of maintenance poly ADP-ribose polymerase inhibition with rucaparib following chemotherapy for metastatic urothelial carcinoma}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{}},

 year = {{2022}},

 month = {{8}},

 author = {{Crabb SJ and Hussain S and Soulis E and Hinsley S and Dempsey L and Trevethan A and Song Y and Barber J and Frew J and Gale J and Faust G et al}},

 doi = {{10.1200/jco.22.00405}},

 volume = {{41}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{1}},

 pages = {{54-64}},

 note = {{Accessed on 2024/12/21}}}